TrialBritish journal of cancer2024

Results of a randomised Phase II trial of olaparib, chemotherapy or olaparib and cediranib in patients with platinum-resistant ovarian cancer.

Shibani Nicum et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.